Wound Care News and Research

RSS

Spectrum Health Innovations inks licensing agreement with Min-Bio to manufacture trauma surgery basin

Spectrum Health Innovations has signed a licensing agreement with Min-Bio, LLC, of Lowell, Mich. to manufacture a new trauma surgery basin that is a cut above existing designs.

2 Jul 2015

CellResearch receives new patent approval from USPTO for stem cell technology

CellResearch Corporation Pte Ltd, a Singaporean company that specializes in stem cell technology, has received approval for its latest patent on 6 May 2015 from the US Patent and Trademark Office.

18 Jun 2015

University of Bristol researchers develop new technology to increase protection against bacterial infection

A new technology which could increase protection against antibacterial and antifungal infection for weeks, months or years has been developed by researchers at the University of Bristol.

18 Jun 2015

Hill-Rom, Welch Allyn joining forces to advance patient care around the world

Two of the world's leading healthcare technology companies are joining forces to make possible the development of leading-edge solutions that will advance patient care around the world. Hill-Rom Holdings, Inc. and privately-held Welch Allyn, Inc. today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which Hill-Rom will acquire Welch Allyn for approximately $2.05 billion in cash and stock.

17 Jun 2015

Scar management: an interview with Adele Atkinson, Associate Professor, School of Nursing

Scarring has been shown to have a significant impact on patients’ lives. As well as the physical burden associated with skin scarring, psychological strains can also negatively affect the quality of life for patients, with the majority (56%) considering themselves to be ‘abnormal’ due to their scars...

3 Jun 2015

BioStructures announces first application of Prohesion surgical wound technology

BioStructures, LLC, a privately held orthobiologics company, announced today the first application of Prohesion, its new surgical wound technology.

2 Jun 2015

AAWC educates public on current, evidence-based practices in wound care

Educating the community continues to be a major focus of the Association for the Advancement of Wound Care (AAWC), which was incorporated in 1995.

29 May 2015

Covalon's revenue increases 24% to $1,742,672 in second quarter 2015

Covalon Technologies Ltd., an advanced medical technologies company, is delighted to announce its financial results for its second quarter ended March 31, 2015, which includes revenue for three months of $2,180,276 and net income for the quarter of $264,340.

29 May 2015

AlloSource's AlloWrap DS amniotic membrane moved to high-cost reimbursement category

AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that AlloWrap DS, its double-sided human amniotic membrane allograft, has been moved to the high-cost reimbursement category.

29 May 2015

New Bio-Oil research demonstrates need for greater education on scar management

New research from Bio-Oil conducted amongst UK nurses demonstrates the need for greater education and resources on the management of patients with scarring following surgery or trauma.

6 May 2015

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

Lucideon, the materials technology company, together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.

From Lucideon 5 May 2015

MiMedx Group's revenue increases 108% to $40.8 million in first quarter 2015

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.

28 Apr 2015

Getinge secures EUR 160 million loan from EIB for development of new medical devices

The European Investment Bank has provided a EUR 160 million loan to Getinge AB, a global medical technology company, for its research and development in the areas of surgery, intensive care, infection control, care ergonomics and wound care. Getinge’s research addresses unmet medical needs and targets the development of new devices with higher efficiency and safety for increased positive outcomes for both caregivers and patients.

24 Apr 2015

New ACS initiative aims to improve outcomes for patients who require complex wound management

The American College of Surgeons today announced a new initiative to improve outcomes for patients requiring complex wound management. ACS will release a new structured teaching and verification program that utilizes engaging media and self-assessment checklists to educate surgical patients and their families about delivering self-care for wound conditions.

16 Apr 2015

AACN announces recipients of annual research grants

The American Association of Critical-Care Nurses announces the recipients of its annual research grants, with total available funding of $160,000.

8 Apr 2015

MTI Expo 2015 to focus on engineering requirements in the medical technology sector

April 29-30, Ricoh Stadium, Coventry sees the next edition of the Med-Tech Innovation exhibition take place – engineering is the thread that runs through the whole show.

30 Mar 2015

USF scientists identify potential compounds to improve cardiovascular system, small vessel disease

University of South Florida scientists have identified a group of compounds with the potential for beneficial effects on the cardiovascular system and small vessel disease while researching grape seed extracts discovered at USF.

26 Mar 2015

Dipexium Pharmaceuticals reports strong financial results for year ended December 31, 2014

Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical antibiotic peptide, today announced operational, clinical and financial results for the year ended December 31, 2014.

24 Mar 2015

TWi Biotechnology obtains Rare Disease Drug designation in Taiwan for use of AC-203 to treat EBS

TWi Pharmaceuticals, Inc. today announced that its fully owned subsidiary, TWi Biotechnology, Inc., has received the designation of Rare Disease Drug by Taiwan FDA for use of AC-203 to treat Epidermolysis Bullosa Simplex (EBS), and is eligible for applying for coverage under National Health Insurance Administration.

10 Mar 2015

Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus

Regenicin, Inc. a biotechnology company specializing in the development of and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, announced today that it has received the final payment to conclude The Asset Purchase Agreement with Amarantus Bioscience Holdings, Inc.

3 Mar 2015

Wound Care News and Research

Spectrum Health Innovations inks licensing agreement with Min-Bio to manufacture trauma surgery basin

CellResearch receives new patent approval from USPTO for stem cell technology

University of Bristol researchers develop new technology to increase protection against bacterial infection

Hill-Rom, Welch Allyn joining forces to advance patient care around the world

Scar management: an interview with Adele Atkinson, Associate Professor, School of Nursing

BioStructures announces first application of Prohesion surgical wound technology

AAWC educates public on current, evidence-based practices in wound care

Covalon's revenue increases 24% to $1,742,672 in second quarter 2015

AlloSource's AlloWrap DS amniotic membrane moved to high-cost reimbursement category

New Bio-Oil research demonstrates need for greater education on scar management

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

MiMedx Group's revenue increases 108% to $40.8 million in first quarter 2015

Getinge secures EUR 160 million loan from EIB for development of new medical devices

New ACS initiative aims to improve outcomes for patients who require complex wound management

AACN announces recipients of annual research grants

MTI Expo 2015 to focus on engineering requirements in the medical technology sector

USF scientists identify potential compounds to improve cardiovascular system, small vessel disease

Dipexium Pharmaceuticals reports strong financial results for year ended December 31, 2014

TWi Biotechnology obtains Rare Disease Drug designation in Taiwan for use of AC-203 to treat EBS

Regenicin receives final payment to conclude Asset Purchase Agreement with Amarantus

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News